525 results on '"Widmark, Anders"'
Search Results
152. Blood platelets contain tumor-derived RNA biomarkers
153. Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
154. Curative radiation therapy in prostate cancer
155. Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
156. Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial
157. Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol
158. A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel/Prednisolone in Patients with Hormone-Refractory Prostate Cancer
159. Health-related quality of life 10 years after external beam radiotherapy or watchful waiting in patients with localized prostate cancer
160. Time and Bodily Changes in Advanced Prostate Cancer: Talk About Time As Death Approaches
161. Meanings of prostate-specific antigen testing as narrated by men with localized prostate cancer after primary treatment
162. P29. Validation of an in vitro method to study the interactions between bone and prostate cancer cells
163. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005
164. 15-year prospective follow-up of patient-reported outcomes of late bowel toxicity after external beam radiotherapy for localized prostate cancer. A comparison with age-matched controls
165. Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancer.
166. Reclaiming Wellness-Living With Bodily Problems, As Narrated by Men With Advanced Prostate Cancer
167. Living After External Beam Radiotherapy of Localized Prostate Cancer
168. Anticancer Effects of a Plant Lignan 7-Hydroxymatairesinol on a Prostate Cancer Model In Vivo
169. Meanings of the Phenomenon of Fatigue as Narrated by 4 Patients With Cancer in Palliative Care
170. Living With Untreated Localized Prostate Cancer
171. Prospective evaluation of urinary and intestinal side effects after BeamCath® stereotactic dose-escalated radiotherapy of prostate cancer
172. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice
173. Prostate Tumor-Derived Exosomes Down-Regulate NKG2D Expression on Natural Killer Cells and CD8+ T Cells: Mechanism of Immune Evasion.
174. Change in prostate volume during extreme hypofractionation analysed with MRI.
175. Fractionated radiotherapy of rat prostatic adenocarcinoma (Dunning R3327-PAP) in nonanesthetized animals
176. Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapy
177. High-precision conformal radiotherapy (HPCRT) of prostate cancer—a new technique for exact positioning of the prostate at the time of treatment
178. Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma
179. Daily-Diary Evaluated Side-Effects of Conformal versus Conventional Prostatic Cancer Radiotherapy Technique
180. Effects of estrogens and progestogens on the membrane permeability and growth of human prostatic carcinoma cells (PC-3) in vitro
181. Estramustine potentiates the effects of irradiation on the dunning (R3327) rat prostatic adenocarcinoma
182. Early diagnosis and treatment is crucial for neurological recovery after surgery for metastatic spinal cord compression in prostate cancer.
183. Effects of clonidine-induced hypotension and dopamine-induced hypertension on blood flows in prostatic adenocarcinoma (dunning R3327) and normal tissues
184. Radiation doses to Norwegian heart-transplanted patients undergoing annual coronary angiography.
185. Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer.
186. Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controls
187. Do Perceptions of Adverse Events Differ Between Patients and Physicians? Findings From a Randomized, Controlled Trial of Radical Treatment for Prostate Cancer.
188. Establishment and validation of an in vitro co-culture model to study the interactions between bone and prostate cancer cells.
189. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.
190. Blood flow in chronic Achilles tendinosis: Radioactive microsphere study in rabbits
191. Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases.
192. Living after radical prostatectomy for localized prostate cancer. A qualitative analysis of patient narratives*.
193. A Systematic Overview of Radiation Therapy Effects in Urinary Bladder Cancer.
194. New Principles in the Treatment of Prostate Cancer.
195. Daily-diary Evaluated Side Effects of Dose-escalation Radiotherapy of Prostate Cancer Using the Stereotactic Beamcath® Technique.
196. Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma.
197. Acute Side Effects after Dose-Escalation Treatment of Prostate Cancer Using the New Urethral Catheter BeamCath[sup ®] Technique.
198. Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): a dosimetric evaluation.
199. Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects.
200. High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.